anatomic stage iv breast cancer ajcc v8
Showing 76 - 77 of 77
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Negative, HER2/Neu Negative Trial in Portland (Durvalumab, Olaparib)
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Durvalumab
- Olaparib
-
Portland, OregonOHSU Knight Cancer Institute
Nov 18, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,
Completed
- Anatomic Stage IV Breast Cancer AJCC v8
- +6 more
- Imatinib Mesylate
- Letrozole
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2020